TXG EPS Estimates
10x Genomics, Inc.
$73.10
+$1.31(+1.82%)
63
Overall
60
Value
66
Tech
65
Quality
Market Cap
$9.52B
Volume
4.14M
52W Range
$11.16 - $102.81
Target Price
$68.24
TXG EPS estimates: the consensus estimate for 10x Genomics, Inc.'s current fiscal year is -$0.75 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TXG EPS Estimates
- EPS estimate, current quarter
- $-0.27
- EPS estimate, next quarter
- $-0.17
- EPS estimate, current year
- $-0.75
- EPS estimate, next year
- $-0.58
- EPS growth, 3-year
- +37.88%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.35 |
| 2024 | $-1.52 |
| 2023 | $-2.18 |
| 2022 | $-1.46 |
| 2021 | $-0.53 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TXG | $73.10 | +1.8% | 4.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |